Almirall S.A. Logo

Almirall S.A.

ISIN: ES0157097017 | Ticker: ALM | LEI: 95980020140005007996
Sector: Health CareSub-Industry: Health Care Technology
Country: Spain

About Almirall S.A.

Company Description

Almirall is a global biopharmaceutical company focused on skin health. We collaborate with scientists and healthcare professionals to address patient needs through science to improve their lives. Our noble purpose guides our work: “Transform the patients' world by helping them realize their hopes and dreams for a healthy life”. We invest in differentiated and pioneering medical dermatology products to bring our innovative solutions to patients in need.

Year founded

1943

Served area

Worldwide

Headcount

1,765

Headquarters

Ronda General Mitre, 151, 8022 Barcelona – Spain

Financial statements

Download as Excel
Line item in (eur) 01.01.2020 01.01.2021 01.01.2022 01.01.2023
Assets N/A 2,291,114,000.00 2,141,744,000.00 2,147,691,000.00
Noncurrent Assets N/A 1,801,364,000.00 1,642,470,000.00 1,594,973,000.00
Property Plant And Equipment N/A 113,548,000.00 117,413,000.00 124,051,000.00
Goodwill N/A 315,966,000.00 315,966,000.00 315,966,000.00
Intangible Assets Other Than Goodwill N/A 1,009,536,000.00 916,056,000.00 898,677,000.00
Deferred Tax Assets N/A 256,476,000.00 192,500,000.00 182,971,000.00
Other Noncurrent Financial Assets N/A N/A 80,502,000.00 34,655,000.00
Current Assets N/A 489,750,000.00 499,274,000.00 552,718,000.00
Inventories N/A 130,151,000.00 118,632,000.00 130,095,000.00
Trade And Other Current Receivables N/A 111,295,000.00 127,671,000.00 138,261,000.00
Current Tax Assets Current N/A N/A 34,054,000.00 20,817,000.00
Other Current Financial Assets N/A 6,025,000.00 899,000.00 443,000.00
Other Current Nonfinancial Assets N/A 9,991,000.00 11,531,000.00 14,722,000.00
Cash and cash equivalents 117,293,000.00 165,667,000.00 207,386,000.00 248,823,000.00
Equity And Liabilities N/A 2,291,114,000.00 2,141,744,000.00 2,147,691,000.00
Equity 1,280,186,000.00 1,302,966,000.00 1,286,039,000.00 1,318,715,000.00
Issued Capital N/A 21,374,000.00 21,573,000.00 21,782,000.00
Share Premium N/A 273,889,000.00 295,785,000.00 317,315,000.00
Statutory Reserve N/A 4,189,000.00 4,275,000.00 4,275,000.00
Noncurrent Liabilities N/A 513,589,000.00 574,712,000.00 554,363,000.00
Noncurrent Provisions For Employee Benefits N/A 85,641,000.00 77,883,000.00 54,046,000.00
Other Longterm Provisions N/A 35,899,000.00 24,505,000.00 20,746,000.00
Deferred Tax Liabilities N/A 117,382,000.00 75,852,000.00 77,254,000.00
Other Noncurrent Financial Liabilities N/A 224,345,000.00 359,692,000.00 350,758,000.00
Other Noncurrent Nonfinancial Liabilities N/A 19,434,000.00 22,618,000.00 17,624,000.00
Current Liabilities N/A 474,559,000.00 280,993,000.00 274,613,000.00
Trade And Other Current Payables N/A 162,143,000.00 177,800,000.00 184,287,000.00
Current Tax Liabilities Current N/A 21,460,000.00 19,471,000.00 26,643,000.00
Other Current Financial Liabilities N/A 248,300,000.00 12,314,000.00 12,402,000.00
Other Current Nonfinancial Liabilities N/A 36,394,000.00 65,130,000.00 46,181,000.00
Line item in (eur) 01.01.2020/
01.01.2021
01.01.2021/
01.01.2022
01.01.2022/
01.01.2023
Revenue 807,427,000.00 827,195,000.00 863,248,000.00
Other Income 7,062,000.00 9,305,000.00 15,263,000.00
Other Work Performed By Entity And Capitalised 4,941,000.00 8,932,000.00 7,539,000.00
Raw Materials And Consumables Used 177,442,000.00 181,752,000.00 189,324,000.00
Other Employee Expense 177,004,000.00 188,420,000.00 201,660,000.00
Depreciation And Amortisation Expense 123,085,000.00 119,937,000.00 120,636,000.00
Other Expense By Nature 229,005,000.00 247,584,000.00 307,788,000.00
Profit Loss From Operating Activities 92,298,000.00 5,752,000.00 46,866,000.00
Finance Income 1,579,000.00 493,000.00 637,000.00
Finance Costs 18,003,000.00 20,600,000.00 12,785,000.00
Profit Loss Before Tax 79,238,000.00 -9,085,000.00 31,027,000.00
Income Tax Expense Continuing Operations 4,958,000.00 31,774,000.00 26,746,000.00
Profit (loss) 74,280,000.00 -40,859,000.00 4,281,000.00
Profit Loss Attributable To Owners Of Parent 74,280,000.00 -40,859,000.00 4,281,000.00
Line item in (eur) 01.01.2020 01.01.2021 01.01.2022 01.01.2023
Profit (loss) N/A 74,280,000.00 -40,859,000.00 4,281,000.00
Adjustments For Finance Costs N/A 18,003,000.00 20,600,000.00 12,785,000.00
Adjustments For Decrease Increase In Inventories N/A 25,329,000.00 -13,338,000.00 10,695,000.00
Adjustments For Depreciation And Amortisation Expense N/A 123,085,000.00 119,937,000.00 120,636,000.00
Adjustments For Impairment Loss Reversal Of Impairment Loss Recognised In Profit Or Loss N/A -16,197,000.00 -90,844,000.00 0.00
Adjustments For Provisions N/A 3,195,000.00 -3,357,000.00 2,285,000.00
Adjustments For Unrealised Foreign Exchange Losses Gains N/A -742,000.00 2,044,000.00 1,984,000.00
Adjustments For Fair Value Gains Losses N/A 4,106,000.00 3,218,000.00 -5,675,000.00
Adjustments For Losses Gains On Disposal Of Noncurrent Assets N/A -649,000.00 -13,871,000.00 -4,863,000.00
Cash Flows From Used In Operating Activities N/A 112,757,000.00 233,852,000.00 155,102,000.00
Purchase Of Property Plant And Equipment Classified As Investing Activities N/A 11,891,000.00 18,814,000.00 23,007,000.00
Purchase Of Intangible Assets Classified As Investing Activities N/A 64,635,000.00 52,338,000.00 93,473,000.00
Interest Received Classified As Investing Activities N/A 1,082,000.00 28,000.00 170,000.00
Cash Flows From Used In Investing Activities N/A -23,517,000.00 -57,255,000.00 -68,543,000.00
Payments To Acquire Or Redeem Entitys Shares N/A 82,000.00 -596,000.00 -46,000.00
Repayments Of Borrowings Classified As Financing Activities N/A 16,882,000.00 154,488,000.00 10,000,000.00
Payments Of Lease Liabilities Classified As Financing Activities N/A 8,289,000.00 7,772,000.00 7,200,000.00
Dividends Paid Classified As Financing Activities N/A 2,129,000.00 11,746,000.00 12,419,000.00
Interest Paid Classified As Financing Activities N/A 6,536,000.00 6,130,000.00 9,899,000.00
Other Inflows Outflows Of Cash Classified As Financing Activities N/A -6,948,000.00 251,000.00 -5,650,000.00
Cash Flows From Used In Financing Activities N/A -40,866,000.00 -134,878,000.00 -45,122,000.00
Increase (decrease) in cash and cash equivalents after effect of exchange rate changes N/A 48,374,000.00 41,719,000.00 41,437,000.00
Cash and cash equivalents 117,293,000.00 165,667,000.00 207,386,000.00 248,823,000.00

Please note that some sums might not add up.

Filings & Publications

2022

Report
Q1
H1
Q3
FY
Consolidated Report
ESP
Corporate Governance Report
Company Presentation
Sustainability Report
Remuneration Report

2021

Report
Q1
H1
Q3
FY
Consolidated Report
ESP
Corporate Governance Report
Company Presentation
Sustainability Report
Remuneration Report

Insider Trades

Sign up and we will give you access!

Capital markets information

ISIN

ES0157097017

LEI

95980020140005007996

Sector

Health Care

Industry Group

Health Care Equipment & Services

Industry

Health Care Technology

Sub-Industry

Health Care Technology

Listed Stock Exchange

Bolsa de Madrid

Contact Investor Relations department

Stay up to date

Keep yourself informed with the most recent updates on FinancialReports, IPOs, product advancements, and other significant news.